The quantity and the value of bulk drug and drug intermediates imported from other countries including China during the last two years has only grown in the last financial year according to information given by the Ministry of Chemicals and Fertilizers to the Parliament this week.
The import from China alone grew from 264582 MT at a value of ₹23,273 crore in 2021-22 to 300120 MT at the value of ₹25,551 crore in 2022-23.
Responding to question by MPs Goddeti Madhavi, Margani Bharat, N. Reddeppa and Pocha Brahmananda Reddy in Lok Sabha on whether the Government has taken/proposes to take steps to tackle India’s reliance on China for Active Pharmaceutical Ingredients (API) and other pharma products the Minister of State for Chemical and Fertilisers noted that the country imports various bulk drugs/APIs for producing medicines from various countries including China.
